西

Hiroyasu Komiya1, Hideyuki Takeuchi2, Akihiro Ogasawara1

  • 1Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Neuroscience research
|February 8, 2025
PubMed
概括

西波尼莫德是一种基-1-酸盐受体1抗剂,通过抑制炎症酶激活来降低微质细胞中的炎症. 这种机制是它在治疗活跃的继发性渐进性多发性硬化症的有效性的关键.